Whittier Trust CO Chembio Diagnostics, Inc. Transaction History

Whittier Trust CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 26, 2021	SELL	$3.4 - $7.97 $2,125 - $4,981	-625 Reduced 50.0%	625 $2,000
Q4 2020 Jan 29, 2021	BUY	$4.11 - $7.51 $2,568 - $4,693	625 Added 100.0%	1,250 $6,000
Q4 2019 Jan 31, 2020	BUY	$3.94 - $5.76 $2,462 - $3,600	625 New	625 $3,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

Stay updated on Whittier Trust CO with notifications on news.